VanEck’s €7.4bn Dividend Fund Sits Just Below a Record as a June Payout Looms

The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF ended last week at €52.33, a fraction of a percent lower on the day but still perched less than 1% below its 52-week high of €52.86, set in late February. That narrow gap belies a broader strength: the fund has added roughly 8.2% since the start of the year and nearly 26% over the past twelve months.

Income-focused investors have more than capital gains to look forward to. Market watchers expect the next quarterly distribution, due in June, to come in at €0.90 per share — a sharp jump from the €0.21 paid out in March. The calendar marks 4 June 2026 as the likely ex-dividend date. That would bring the trailing dividend yield to around 3.3%, consistent with the fund’s ten-year record of uninterrupted payouts.

The portfolio’s composition is about to face its most intense test of the year. With the first-quarter earnings season in full swing, several of the fund’s top holdings are set to report in the coming days. The ten largest positions account for more than 35% of assets under management, and heavyweights such as Verizon, Pfizer, Nestlé and Allianz are all due to deliver results. Roche, another major pharma name in the fund, has already reported a currency-adjusted sales increase of 6% for the first quarter and reaffirmed its full-year guidance.

Sector allocations add another layer of scrutiny. Financials and energy stocks dominate the ETF’s portfolio, with banks expected to post earnings growth of more than 15% this season. The healthcare sector looks softer on the surface, but analysts say that stripping out one-off items reveals underlying earnings growth as well.

Should investors sell immediately? Or is it worth buying VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF?

The macro calendar adds to the pressure. On Thursday, the US government publishes its first estimate of first-quarter economic growth — a release that typically triggers sharp market reactions. If the data shows sluggish expansion alongside sticky inflation, the Federal Reserve’s room for manoeuvre would shrink considerably. Rate-sensitive dividend strategies tend to react acutely to such shifts in monetary policy expectations.

Technically, the fund remains comfortably above its moving averages, with a relative strength index of roughly 49 — neutral territory that suggests neither overbought nor oversold conditions. The annualised 30-day volatility of around 10% underscores the defensive character that has made this ETF a staple for income investors.

The fund tracks the Morningstar Developed Markets Large Cap Dividend Leaders Screened Select Index, a basket of 100 stocks from developed markets filtered for dividend policy, market capitalisation, liquidity and ESG criteria. With €7.4 billion in assets, it is one of the largest vehicles of its kind in Europe. Annual costs run at 0.38%, and index rebalancing takes place twice a year, in June and December.

Thursday’s dual test — US GDP data and a wave of European earnings — will go a long way toward determining whether the fund can push past its current high and extend its rally into the June ex-dividend date. A robust growth reading combined with solid corporate results would likely reinforce the upward trend. A miss on either front could leave the ETF consolidating just below that record level a while longer.